Alobaida has served as founder and CEO of Sudair Pharmaceutical Company since its establishment in 2014. He oversaw the launch of SPC’s first state-of-the-art facility in Sudair Industrial City in 2015. Under his leadership, SPC signed eight strategic memoranda of cooperation with leading universities to develop national pharmaceutical talent, including the 2025 agreement with Qassim University. In 2024, SPC finalized an offtake and technology transfer agreement with Sanofi and NUPCO to localize insulin production in Saudi Arabia. Alobaida also serves on multiple boards, including Halal Products Development Company, Saudi Commission for Health Specialties.